Heppenheim, Germany

Christian Kliem


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christian Kliem: Innovator in Nucleic Acid Modification

Introduction

Christian Kliem is a notable inventor based in Heppenheim, Germany. He has made significant contributions to the field of nucleic acid modification, holding a total of 2 patents. His work focuses on innovative methods that enhance the functionality of nucleic acids, which are essential for various biological processes.

Latest Patents

Kliem's latest patents include a method and a kit for the post-synthetic modification of nucleic acids via an inverse Diels-Alder reaction. This invention provides a novel approach to modifying nucleic acids, which can have far-reaching implications in biotechnology and medicine. Another significant patent involves a process for the covalent coupling of two molecules using a Diels-Alder reaction with inverse electron requirement. This process outlines the steps for linking molecules effectively, showcasing Kliem's expertise in chemical reactions and molecular interactions.

Career Highlights

Throughout his career, Christian Kliem has worked with prestigious organizations, including the German Cancer Research Center (Deutsches Krebsforschungszentrum). His research has contributed to advancements in cancer research and therapeutic development, highlighting his commitment to improving health outcomes through innovation.

Collaborations

Kliem has collaborated with esteemed colleagues such as Manfred Wiessler and Peter Lorenz. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.

Conclusion

Christian Kliem's contributions to the field of nucleic acid modification exemplify the importance of innovation in scientific research. His patents and collaborations reflect a dedication to advancing knowledge and technology in the life sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…